A prospective, multiple center trial for incidence and prevention of hepatitis B virus (HBV) reactivation following hematopoietic stem cell transplantation (HSCT)
Not Applicable
- Conditions
- Patients with resolved HBV infection who receive hematopoietic stem cell transplantation
- Registration Number
- JPRN-UMIN000011543
- Lead Sponsor
- Kiminori Kimura
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with HCV antibody positive 2. Patients with HIV antibody positive 3. Patients who are allergic to vaccination 4. Patients who are allergic to biologics 5. Patients with severe infectious disease (Patients whose general condition seemed to be poor like as septic shock ) 6. Patient who undergo hemodialysis 7. Patients with mental disorder which is object of treatment 8. Patients with poorly controlled DM, HT, or heart failure 9. Patients who are pregnant or nursing 10. Patients who are judged ineligible for this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of HBV reactivation in HSCT recipients immunized with HB vaccination.
- Secondary Outcome Measures
Name Time Method